Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04291885
Title Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma (I-MAT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Melanoma and Skin Cancer Trials Limited
Indications

Merkel cell carcinoma

Therapies

Avelumab

Age Groups: senior | adult
Covered Countries


No variant requirements are available.